Miriam Provost - 31 Aug 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
VP, Global Regulatory Affairs
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
31 Aug 2023
Net transactions value
-$32,279
Form type
4
Filing time
05 Sep 2023, 16:36:40 UTC
Previous filing
22 Feb 2023
Next filing
15 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $5,748 +1,785 +8.6% $3.22* 22,624 31 Aug 2023 Direct
transaction TMDX Common Stock Options Exercise $142,110 +3,695 +16% $38.46 26,319 31 Aug 2023 Direct F1
transaction TMDX Common Stock Sale $180,136 -2,708 -10% $66.52 23,611 31 Aug 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -1,785 -9.8% $0.000000 16,496 31 Aug 2023 Common Stock 1,785 $3.22 Direct F4
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -3,695 -24% $0.000000 11,410 31 Aug 2023 Common Stock 3,695 $38.46 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $66.40 to $66.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F4 The option is fully vested.
F5 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.